NEPH: Nephros Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Nephros Inc (NEPH).
$15.50M Market Cap.
NEPH Market Cap. (MRY)
NEPH Shares Outstanding (MRY)
NEPH Assets (MRY)
Total Assets
$11.21M
Total Liabilities
$2.63M
Total Investments
$0
NEPH Income (MRY)
Revenue
$14.16M
Net Income
$74.00K
Operating Expense
$8.72M
NEPH Cash Flow (MRY)
CF Operations
-$492.00K
CF Investing
-$50.00K
CF Financing
-$5.00K
NEPH Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $11,210,000 (-5.49%) | $11,861,000 (7.84%) | $10,999,000 (-37.68%) | $17,650,000 (-4.65%) |
Assets Current | $8,298,000 (-1.27%) | $8,405,000 (1.74%) | $8,261,000 (-39.41%) | $13,634,000 (-10.03%) |
Assets Non-Current | $2,912,000 (-15.74%) | $3,456,000 (26.22%) | $2,738,000 (-31.82%) | $4,016,000 (19.67%) |
Goodwill & Intangible Assets | $1,324,000 (-6.17%) | $1,411,000 (-10.92%) | $1,584,000 (-10.00%) | $1,760,000 (-9.04%) |
Shareholders Equity | $8,585,000 (2.72%) | $8,358,000 (49.46%) | $5,592,000 (-52.18%) | $11,695,000 (-6.60%) |
Property Plant & Equipment Net | $1,538,000 (-21.49%) | $1,959,000 (78.09%) | $1,100,000 (60.35%) | $686,000 (-48.50%) |
Cash & Equivalents | $3,760,000 (-12.70%) | $4,307,000 (18.52%) | $3,634,000 (-47.88%) | $6,973,000 (-15.47%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $64,000 (-13.51%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $2,615,000 (5.87%) | $2,470,000 (-21.66%) | $3,153,000 (-29.34%) | $4,462,000 (-15.87%) |
Trade & Non-Trade Receivables | $1,781,000 (19.05%) | $1,496,000 (16.33%) | $1,286,000 (-21.63%) | $1,641,000 (20.31%) |
Trade & Non-Trade Payables | $649,000 (-25.66%) | $873,000 (17.97%) | $740,000 (-44.53%) | $1,334,000 (215.37%) |
Accumulated Retained Earnings (Deficit) | -$144,332,000 (0.05%) | -$144,406,000 (-1.10%) | -$142,831,000 (-5.24%) | -$135,725,000 (-2.93%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,411,000 (-23.15%) | $1,836,000 (67.98%) | $1,093,000 (9.30%) | $1,000,000 (-53.98%) |
Debt Current | $348,000 (-21.97%) | $446,000 (15.25%) | $387,000 (-31.02%) | $561,000 (0.00%) |
Debt Non-Current | $1,063,000 (-23.53%) | $1,390,000 (96.88%) | $706,000 (60.82%) | $439,000 (-72.77%) |
Total Liabilities | $2,625,000 (-25.06%) | $3,503,000 (65.39%) | $2,118,000 (-26.99%) | $2,901,000 (-1.23%) |
Liabilities Current | $1,562,000 (-26.08%) | $2,113,000 (49.65%) | $1,412,000 (-40.92%) | $2,390,000 (80.38%) |
Liabilities Non-Current | $1,063,000 (-23.53%) | $1,390,000 (96.88%) | $706,000 (38.16%) | $511,000 (-68.30%) |
NEPH Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $14,162,000 (-0.53%) | $14,238,000 (42.74%) | $9,975,000 (-2.37%) | $10,217,000 (19.34%) |
Cost of Revenue | $5,439,000 (-6.75%) | $5,833,000 (11.23%) | $5,244,000 (14.40%) | $4,584,000 (25.66%) |
Selling General & Administrative Expense | $7,676,000 (-13.86%) | $8,911,000 (17.36%) | $7,593,000 (5.53%) | $7,195,000 (11.27%) |
Research & Development Expense | $906,000 (3.78%) | $873,000 (-30.44%) | $1,255,000 (-16.22%) | $1,498,000 (-45.70%) |
Operating Expenses | $8,717,000 (-12.81%) | $9,998,000 (10.28%) | $9,066,000 (2.04%) | $8,885,000 (-5.65%) |
Interest Expense | $1,000 (-50.00%) | $2,000 (-90.00%) | $20,000 (-51.22%) | $41,000 (-62.73%) |
Income Tax Expense | $15,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $2,829,000 (161.22%) | $1,083,000 (0%) |
Consolidated Income | $74,000 (104.70%) | -$1,575,000 (77.84%) | -$7,106,000 (-83.76%) | -$3,867,000 (14.56%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $276,000 (15.00%) | $240,000 (0.00%) |
Net Income | $74,000 (104.70%) | -$1,575,000 (78.66%) | -$7,382,000 (-79.74%) | -$4,107,000 (13.83%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $74,000 (104.70%) | -$1,575,000 (78.66%) | -$7,382,000 (-79.74%) | -$4,107,000 (13.83%) |
Weighted Average Shares | $10,525,197 (1.34%) | $10,386,018 (0.86%) | $10,297,134 (2.79%) | $10,017,830 (10.35%) |
Weighted Average Shares Diluted | $10,602,004 (2.08%) | $10,386,018 (0.86%) | $10,297,134 (2.79%) | $10,017,830 (10.35%) |
Earning Before Interest & Taxes (EBIT) | $90,000 (105.72%) | -$1,573,000 (78.63%) | -$7,362,000 (-81.06%) | -$4,066,000 (12.67%) |
Gross Profit | $8,723,000 (3.78%) | $8,405,000 (77.66%) | $4,731,000 (-16.01%) | $5,633,000 (14.65%) |
Operating Income | $6,000 (100.38%) | -$1,593,000 (63.25%) | -$4,335,000 (-33.30%) | -$3,252,000 (27.80%) |
NEPH Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$50,000 (33.33%) | -$75,000 (45.26%) | -$137,000 (-61.18%) | -$85,000 (64.44%) |
Net Cash Flow from Financing | -$5,000 (93.67%) | -$79,000 (-332.35%) | $34,000 (-85.65%) | $237,000 (-97.89%) |
Net Cash Flow from Operations | -$492,000 (-159.49%) | $827,000 (125.57%) | -$3,234,000 (-128.23%) | -$1,417,000 (79.47%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$547,000 (-181.28%) | $673,000 (120.16%) | -$3,339,000 (-161.68%) | -$1,276,000 (-131.25%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | -$49,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$50,000 (33.33%) | -$75,000 (45.26%) | -$137,000 (-280.56%) | -$36,000 (84.94%) |
Issuance (Repayment) of Debt Securities | -$5,000 (93.67%) | -$79,000 (72.38%) | -$286,000 (-8.33%) | -$264,000 (17.76%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $0 (0%) | $163,000 (-67.47%) | $501,000 (-95.69%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | -$2,000 (81.82%) | -$11,000 (-222.22%) |
Share Based Compensation | $153,000 (-85.46%) | $1,052,000 (7.13%) | $982,000 (-22.00%) | $1,259,000 (61.62%) |
Depreciation Amortization & Accretion | $137,000 (-35.98%) | $214,000 (-39.03%) | $351,000 (39.29%) | $252,000 (21.15%) |
NEPH Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 61.60% (4.41%) | 59.00% (24.47%) | 47.40% (-13.97%) | 55.10% (-4.01%) |
Profit Margin | 0.50% (104.50%) | -11.10% (85.00%) | -74.00% (-84.08%) | -40.20% (27.83%) |
EBITDA Margin | 1.60% (116.84%) | -9.50% (86.49%) | -70.30% (-88.47%) | -37.30% (28.27%) |
Return on Average Equity (ROAE) | 0.90% (104.95%) | -18.20% (80.72%) | -94.40% (-178.47%) | -33.90% (27.56%) |
Return on Average Assets (ROAA) | 0.70% (104.90%) | -14.30% (74.42%) | -55.90% (-143.04%) | -23.00% (17.27%) |
Return on Sales (ROS) | 0.60% (105.45%) | -11.00% (85.09%) | -73.80% (-85.43%) | -39.80% (26.84%) |
Return on Invested Capital (ROIC) | 1.40% (104.28%) | -32.70% (73.71%) | -124.40% (-127.42%) | -54.70% (8.38%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | 147 (737.27%) | -23.07 (-1295.46%) | -1.65 (89.07%) | -15.13 (8.32%) |
Price to Sales Ratio (P/S) | 1.09 (-56.70%) | 2.52 (111.21%) | 1.2 (-79.34%) | 5.79 (-36.42%) |
Price to Book Ratio (P/B) | 1.8 (-58.41%) | 4.34 (103.28%) | 2.13 (-58.64%) | 5.16 (-23.63%) |
Debt to Equity Ratio (D/E) | 0.31 (-26.97%) | 0.42 (10.55%) | 0.38 (52.82%) | 0.25 (5.53%) |
Earnings Per Share (EPS) | 0.01 (106.67%) | -0.15 (78.57%) | -0.7 (-79.49%) | -0.39 (25.00%) |
Sales Per Share (SPS) | 1.35 (-1.82%) | 1.37 (41.49%) | 0.97 (-5.00%) | 1.02 (8.17%) |
Free Cash Flow Per Share (FCFPS) | -0.05 (-170.83%) | 0.07 (122.02%) | -0.33 (-125.52%) | -0.14 (81.58%) |
Book Value Per Share (BVPS) | 0.82 (1.37%) | 0.81 (48.25%) | 0.54 (-53.47%) | 1.17 (-15.37%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.94 (-6.66%) | 1.01 (10.07%) | 0.91 (-42.37%) | 1.59 (-13.14%) |
Enterprise Value Over EBIT (EV/EBIT) | 162 (871.43%) | -21 (-2000.00%) | -1 (92.31%) | -13 (27.78%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 64.03 (368.28%) | -23.87 (-1851.51%) | -1.22 (91.41%) | -14.24 (22.58%) |
Asset Turnover | 1.28 (-0.62%) | 1.29 (71.13%) | 0.76 (31.99%) | 0.57 (14.86%) |
Current Ratio | 5.31 (33.53%) | 3.98 (-32.01%) | 5.85 (2.56%) | 5.71 (-50.12%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$542,000 (-172.07%) | $752,000 (122.31%) | -$3,371,000 (-132.00%) | -$1,453,000 (79.66%) |
Enterprise Value (EV) | $14,535,011 (-55.19%) | $32,435,865 (278.42%) | $8,571,366 (-84.22%) | $54,301,190 (-33.61%) |
Earnings Before Tax (EBT) | $89,000 (105.65%) | -$1,575,000 (78.66%) | -$7,382,000 (-79.74%) | -$4,107,000 (13.83%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $227,000 (116.70%) | -$1,359,000 (80.62%) | -$7,011,000 (-83.82%) | -$3,814,000 (14.25%) |
Invested Capital | $5,975,000 (1.86%) | $5,866,000 (7.40%) | $5,462,000 (-27.43%) | $7,527,000 (-17.95%) |
Working Capital | $6,736,000 (7.06%) | $6,292,000 (-8.13%) | $6,849,000 (-39.09%) | $11,244,000 (-18.69%) |
Tangible Asset Value | $9,886,000 (-5.40%) | $10,450,000 (10.99%) | $9,415,000 (-40.75%) | $15,890,000 (-4.13%) |
Market Capitalization | $15,500,011 (-57.27%) | $36,277,865 (203.88%) | $11,938,366 (-80.23%) | $60,375,190 (-28.67%) |
Average Equity | $8,216,250 (-4.82%) | $8,632,250 (10.40%) | $7,818,750 (-35.37%) | $12,098,000 (18.79%) |
Average Assets | $11,028,000 (0.04%) | $11,023,250 (-16.51%) | $13,203,750 (-26.03%) | $17,849,250 (3.93%) |
Invested Capital Average | $6,361,750 (32.39%) | $4,805,250 (-18.79%) | $5,917,250 (-20.34%) | $7,428,250 (-4.71%) |
Shares | 10,544,225 (0.57%) | 10,484,932 (1.63%) | 10,316,597 (0.82%) | 10,233,083 (3.73%) |